PLATINUM INVESTMENT MANAGEMENT LTD - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 54 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.0%.

Quarter-by-quarter ownership
PLATINUM INVESTMENT MANAGEMENT LTD ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$302,757
-53.4%
545,5080.0%0.01%
-55.6%
Q3 2022$649,000
+88.1%
545,5080.0%0.03%
+107.7%
Q2 2022$345,000
-44.5%
545,5080.0%0.01%
-31.6%
Q1 2022$622,000
-49.3%
545,5080.0%0.02%
-44.1%
Q4 2021$1,227,000
-34.2%
545,5080.0%0.03%
-35.8%
Q3 2021$1,866,000
+18.4%
545,508
+3.5%
0.05%
+47.2%
Q2 2021$1,576,000
-7.5%
527,1010.0%0.04%
-5.3%
Q1 2021$1,703,000
+6.3%
527,101
-30.2%
0.04%
+2.7%
Q4 2020$1,602,000
+48.7%
755,593
-17.9%
0.04%
+37.0%
Q3 2020$1,077,000
+29.4%
920,2940.0%0.03%
+42.1%
Q2 2020$832,000
+7.9%
920,2940.0%0.02%0.0%
Q1 2020$771,000
-29.4%
920,294
-19.1%
0.02%
-13.6%
Q4 2019$1,092,000
-6.8%
1,137,6470.0%0.02%
-15.4%
Q3 2019$1,172,000
-42.8%
1,137,6470.0%0.03%
-45.8%
Q2 2019$2,048,000
-4.3%
1,137,6470.0%0.05%
-4.0%
Q1 2019$2,139,000
+59.4%
1,137,6470.0%0.05%
+11.1%
Q4 2018$1,342,000
-50.0%
1,137,647
+14.8%
0.04%
-40.8%
Q3 2018$2,685,000
+24.4%
990,748
-12.4%
0.08%
+49.0%
Q2 2018$2,159,000
-20.9%
1,130,432
-13.0%
0.05%
-32.9%
Q1 2018$2,728,000
+4.5%
1,299,232
+1.0%
0.08%
+10.1%
Q4 2017$2,610,000
+39.1%
1,286,032
-8.9%
0.07%
+46.8%
Q3 2017$1,877,000
+47.6%
1,411,832
+74.3%
0.05%
+34.3%
Q2 2017$1,272,000
-51.4%
810,2320.0%0.04%
-52.1%
Q1 2017$2,617,000
+289.4%
810,232
+62.6%
0.07%
+265.0%
Q4 2016$672,000
-13.5%
498,2320.0%0.02%
+11.1%
Q3 2016$777,000
+17.4%
498,2320.0%0.02%
+12.5%
Q2 2016$662,000
-39.3%
498,232
+140.8%
0.02%
-33.3%
Q1 2016$1,090,000
-5.5%
206,932
+40.8%
0.02%
-4.0%
Q4 2015$1,153,000
+26.4%
146,932
+36.1%
0.02%0.0%
Q3 2015$912,000
-22.8%
107,9320.0%0.02%
+4.2%
Q2 2015$1,181,000
-21.7%
107,9320.0%0.02%
-20.0%
Q1 2015$1,508,000
-17.2%
107,9320.0%0.03%
-14.3%
Q4 2014$1,822,000
+25.8%
107,9320.0%0.04%
+20.7%
Q3 2014$1,448,000
+38.8%
107,932
+31.7%
0.03%
+61.1%
Q2 2014$1,043,000
+99.8%
81,932
+86.5%
0.02%
+100.0%
Q1 2014$522,000
-13.9%
43,9320.0%0.01%
-10.0%
Q4 2013$606,000
-20.8%
43,9320.0%0.01%
-28.6%
Q3 2013$765,000
+126.3%
43,932
+109.9%
0.01%
+133.3%
Q2 2013$338,00020,9320.01%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
BVF INC/IL 6,353,645$4,017,0000.19%
Gratus Capital, LLC 1,117,154$706,0000.08%
Bleichroeder LP 250,000$158,0000.03%
Polar Capital Holdings Plc 5,000,000$3,162,0000.02%
PLATINUM INVESTMENT MANAGEMENT LTD 545,508$345,0000.01%
Ergoteles LLC 419,652$265,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 249,000$157,0000.00%
Y-Intercept (Hong Kong) Ltd 41,396$26,0000.00%
Heritage Financial Services, LLC 4,749$3,0000.00%
Evercore Wealth Management, LLC 143,138$91,0000.00%
View complete list of INFINITY PHARMACEUTICALS INC shareholders